Other languages Cathay Biotech Inc.

Equities

688065

CNE100004447

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 28/04/2024 BST			5-day change	1st Jan Change
49.16 ^CNY	+12.99%		+22.53%	-10.59%

04-15	Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	MT
04-02	Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	04-15
Cathay Biotech's 2023 Profit Drops 34% as Revenue Falls 13%	02-26
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23
Cathay Biotech Inc. and 3P.Com Co. Limited Signs Joint Venture Agreement to Propel Sustainable Composite Innovations	02-08
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
HBM Healthcare kauft trotz höherem Verlust Aktien zurück	16/10/23
HBM confirme sa perte nette au premier semestre 2022/23	16/10/23
HBM Healthcare anticipe une perte semestrielle de 70 millions	02/10/23
HBM Healthcare erwartet Verlust von 70 Millionen im Halbjahr	02/10/23
Cathay Biotech Inc. announces an Equity Buyback for CNY 100 million worth of its shares.	17/08/23
Cathay Biotech Inc. authorizes a Buyback Plan.	16/08/23
Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	03/08/23
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	26/06/23
Morning Briefing - Markt Schweiz	26/06/23
HBM-Portfoliofirma Cathay Biotech geht neue Zusammenarbeit ein	26/06/23
HBM Healthcare Investments a creusé ses pertes en 2022/23	12/05/23
HBM Healthcare schliesst auch 2022/23 mit Verlust ab	12/05/23
Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
HBM confirme sa perte sur les neuf premiers mois de l'exercice en cours	20/01/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cathay Biotech Inc.

Equities

688065

CNE100004447

Other languages

Filters